Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats

We conclude that the highly renoprotective capacity of mesenchymal stem cells opens the possibility for a cell-based paradigm shift in the treatment of I/R ARF.